CIK: 0001855655 · Show all filings
Period: Q4 2025 (← Previous)
Filing Date: Feb 17, 2026
Total Value ($000): $3,917,830 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| ORKA | ORUKA THERAPEUTICS INC | 1,710,316 | $51,840 | 1.3% | $27.86 | 0.0% | COM | 687604108 |
| LXEO | LEXEO THERAPEUTICS INC | 4,763,198 | $47,299 | 1.2% | $9.13 | 0.0% | COM | 52886X107 |
| TERN | TERNS PHARMACEUTICALS INC | 810,286 | $32,736 | 0.8% | $23.11 | 0.0% | COM | 880881107 |
| VOR | VOR BIOPHARMA INC | 1,750,000 | $22,890 | 0.6% | $18.62 | 0.0% | COM NEW | 929033207 |
| ASMB | ASSEMBLY BIOSCIENCES INC | 665,251 | $22,625 | 0.6% | $32.21 | 0.0% | COM NEW | 045396207 |
| ORIC | ORIC PHARMACEUTICALS INC | 2,401,217 | $19,642 | 0.5% | $11.51 | 0.0% | COM | 68622P109 |
| IVA | INVENTIVA SA | 4,000,000 | $18,600 | 0.5% | $4.65 | — | ADS | 46124U107 |
| KLRS | KALARIS THERAPEUTICS INC | 700,000 | $5,908 | 0.2% | $6.39 | 0.0% | COM | 482929106 |
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| RVMD | REVOLUTION MEDICINES INC | 6,644,403 (+6.8%) | $529,227 (+82.1%) | 13.5% | $38.36 | +70.9% | COM | 76155X100 |
| OLMA | OLEMA PHARMACEUTICALS INC | 7,544,172 (+11.0%) | $188,604 (+183.6%) | 4.8% | $9.20 | +93.4% | COM | 68062P106 |
| GMAB | GENMAB A/S | 7,039,834 (+84.4%) | $216,827 (+85.2%) | 5.5% | $30.73 | — | SPONSORED ADS | 372303206 |
| XBI | SPDR SERIES TRUST | 1,500,000 (+50.0%) | $182,895 (+82.5%) | 4.7% | — | — | PUT | 78464A870 |
| EWTX | EDGEWISE THERAPEUTICS INC | 6,541,210 (+6.0%) | $162,320 (+62.2%) | 4.1% | $20.10 | -0.1% | COM | 28036F105 |
| SRRK | SCHOLAR ROCK HLDG CORP | 3,062,157 (+52.4%) | $134,888 (+80.2%) | 3.4% | $33.97 | +10.4% | COM | 80706P103 |
| PCVX | VAXCYTE INC | 4,068,020 (+7.5%) | $187,698 (+37.7%) | 4.8% | $55.45 | -19.3% | COM | 92243G108 |
| EYPT | EYEPOINT INC | 3,691,475 (+84.1%) | $67,443 (+136.2%) | 1.7% | $12.73 | +11.4% | COM NEW | 30233G209 |
| ERAS | ERASCA INC | 14,159,095 (+4.4%) | $52,672 (+78.2%) | 1.3% | $2.22 | +26.9% | COM | 29479A108 |
| URGN | UROGEN PHARMA LTD | 4,473,648 (+6.1%) | $104,773 (+24.6%) | 2.7% | $18.17 | +19.4% | COM | M96088105 |
| ACLX | ARCELLX INC | 5,724,016 (+23.1%) | $373,206 (-2.2%) | 9.5% | $48.76 | +63.6% | COMMON STOCK | 03940C100 |
| BBOT | BRIDGEBIO ONCOLOGY THERAPEUT | 2,261,749 (+21.2%) | $28,317 (+31.0%) | 0.7% | $11.74 | — | COM NEW | 107924102 |
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | MERUS N V | 4,373,770 | $411,790 | 10.5% | $51.34 | — | — | N5749R100 |
| AGIO | AGIOS PHARMACEUTICALS INC | 2,673,555 | $107,316 | 2.7% | $34.49 | +1.7% | — | 00847X104 |
| JANX | JANUX THERAPEUTICS INC | 2,920,258 | $71,371 | 1.8% | $48.02 | -51.0% | — | 47103J105 |
| ALKS | ALKERMES PLC | 1,719,334 | $51,580 | 1.3% | $29.45 | +1.7% | — | G01767105 |
| LENZ | LENZ THERAPEUTICS INC | 1,073,461 | $50,002 | 1.3% | $27.56 | +5.8% | — | 52635N103 |
| PHVS | PHARVARIS N V | 1,835,494 | $45,796 | 1.2% | $18.67 | +29.0% | — | N69605108 |
| COGT | COGENT BIOSCIENCES INC | 3,156,398 | $45,326 | 1.2% | $7.69 | +265.7% | — | 19240Q201 |
| — | MERUS N V | 300,000 | $28,245 | 0.7% | $51.34 | — | CALL | N5749R100 |
| TNGX | TANGO THERAPEUTICS INC | 3,086,184 | $25,924 | 0.7% | $6.77 | +27.3% | — | 87583X109 |
| AMLX | AMYLYX PHARMACEUTICALS INC | 1,900,000 | $25,821 | 0.7% | $9.41 | +44.3% | — | 03237H101 |
| DYN | DYNE THERAPEUTICS INC | 1,898,950 | $24,022 | 0.6% | $11.41 | +66.0% | — | 26818M108 |
| IRON | DISC MEDICINE INC | 247,716 | $16,369 | 0.4% | $48.64 | +73.7% | — | 254604101 |
| GPCR | STRUCTURE THERAPEUTICS INC | 372,869 | $10,440 | 0.3% | $28.00 | — | — | 86366E106 |
| AGIO | AGIOS PHARMACEUTICALS INC | 200,000 | $8,028 | 0.2% | $34.49 | +1.7% | CALL | 00847X104 |
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | CIDARA THERAPEUTICS INC | 759,565 (-21.0%) | $167,780 (+82.3%) | 4.3% | $95.76 | — | COM NEW | 171757206 |
| ABVX | ABIVAX SA | 1,417,473 (-9.4%) | $191,153 (+43.9%) | 4.9% | $84.90 | — | SPONSORED ADS | 00370M103 |
| TARS | TARSUS PHARMACEUTICALS INC | 2,562,154 (-3.9%) | $209,789 (+32.4%) | 5.4% | $28.61 | +161.0% | COM | 87650L103 |
| APGE | APOGEE THERAPEUTICS INC | 1,123,243 (-26.2%) | $84,782 (+40.2%) | 2.2% | $44.51 | +41.5% | COM | 03770N101 |
| VRDN | VIRIDIAN THERAPEUTICS INC | 1,443,102 (-44.7%) | $44,909 (-20.2%) | 1.1% | $17.86 | +53.5% | COM | 92790C104 |
| OCUL | OCULAR THERAPEUTIX INC | 2,935,284 (-16.1%) | $35,634 (-12.8%) | 0.9% | $7.86 | +54.4% | COM | 67576A100 |
| CRNX | CRINETICS PHARMACEUTICALS IN | 2,210,774 (-13.3%) | $102,912 (-3.1%) | 2.6% | $26.84 | +65.9% | COM | 22663K107 |
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| NUVL | NUVALENT INC | 5,269,433 | $530,052 | 13.5% | $60.72 | +62.4% | COM | 670703107 |
| SYRE | SPYRE THERAPEUTICS INC | 1,467,266 | $48,068 | 1.2% | $26.04 | +0.3% | COM NEW | 00773J202 |
| BBIO | BRIDGEBIO PHARMA INC | 684,277 | $52,340 | 1.3% | $36.37 | +80.5% | COM | 10806X102 |